Raza A - Search Results

1

The impact of hypomethylating agents on the cost of care and survival of elderly patients with myelodysplastic syndromes.

Wang R, Gross CP, Frick K, Xu X, Long J, Raza A, Galili N, Zikria J, Guan Y, Ma X. Wang R, et al. Among authors: raza a. Leuk Res. 2012 Nov;36(11):1370-5. doi: 10.1016/j.leukres.2012.07.020. Epub 2012 Aug 20. Leuk Res. 2012. PMID: 22917770 Free PMC article.

2

Clinical response of myelodysplastic syndromes patients to treatment with coenzyme Q10.

Galili N, Sechman EV, Cerny J, Mehdi M, Mumtaz M, Westervelt P, Maguire J, Raza A. Galili N, et al. Among authors: raza a. Leuk Res. 2007 Jan;31(1):19-26. doi: 10.1016/j.leukres.2006.04.009. Epub 2006 Oct 24. Leuk Res. 2007. PMID: 17064768 Clinical Trial.

3

Clustering in the incidence of myelodysplastic syndromes.

Ma X, Selvin S, Raza A, Foti K, Mayne ST. Ma X, et al. Among authors: raza a. Leuk Res. 2007 Dec;31(12):1683-6. doi: 10.1016/j.leukres.2007.03.032. Epub 2007 May 15. Leuk Res. 2007. PMID: 17507092

4

Pattern of hypomethylating agents use among elderly patients with myelodysplastic syndromes.

Wang R, Gross CP, Maggiore RJ, Halene S, Soulos PR, Raza A, Galili N, Ma X. Wang R, et al. Among authors: raza a. Leuk Res. 2011 Jul;35(7):904-8. doi: 10.1016/j.leukres.2010.10.007. Epub 2010 Nov 9. Leuk Res. 2011. PMID: 21067809 Free PMC article.

5

Cigarette smoking shortens the survival of patients with low-risk myelodysplastic syndromes.

Ma X, Wang R, Galili N, Mayne ST, Wang SA, Yu H, Raza A. Ma X, et al. Among authors: raza a. Cancer Causes Control. 2011 Apr;22(4):623-9. doi: 10.1007/s10552-011-9735-6. Epub 2011 Feb 2. Cancer Causes Control. 2011. PMID: 21287258 Free PMC article.

6

Myelodysplastic syndromes: incidence and survival in the United States.

Ma X, Does M, Raza A, Mayne ST. Ma X, et al. Among authors: raza a. Cancer. 2007 Apr 15;109(8):1536-42. doi: 10.1002/cncr.22570. Cancer. 2007. PMID: 17345612 Free article.

7

Clinical implications of gene expression profiling in myelodysplastic syndromes: recognition of ribosomal and translational gene dysregulation and development of predictive assays.

Galili N, Raza A. Galili N, et al. Among authors: raza a. Best Pract Res Clin Haematol. 2009 Jun;22(2):223-37. doi: 10.1016/j.beha.2009.04.006. Best Pract Res Clin Haematol. 2009. PMID: 19698930

8

Pharmacotherapy of myelodysplastic syndromes.

Galili N, Raza A. Galili N, et al. Among authors: raza a. Expert Opin Pharmacother. 2010 Aug;11(11):1889-99. doi: 10.1517/14656566.2010.485613. Expert Opin Pharmacother. 2010. PMID: 20486832 Review.

9

The biology and treatment of myelodysplastic syndromes.

Raza A, Galili N. Raza A, et al. Rinsho Ketsueki. 2013 Oct;54(10):1730-6. Rinsho Ketsueki. 2013. PMID: 24064823 Review. No abstract available.

10

Translational research in myelodysplastic syndromes.

Raza A, Qawi H, Mehdi M, Mumtaz M, Galili N. Raza A, et al. Rev Clin Exp Hematol. 2004 Dec 1;8(2):E2. Rev Clin Exp Hematol. 2004. PMID: 16027100 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,674 results

Search Page